Warner Chilcott Targets Ranbaxy's Osteoporosis Generic
Warner Chilcott Co. LLC on Thursday redoubled its efforts to protect its osteoporosis drug Atelvia, launching a new infringement suit accusing Ranbaxy Laboratories Ltd. of violating its patents by developing a...To view the full article, register now.
Already a subscriber? Click here to view full article